- Home
- Publications
- Publication Search
- Publication Details
Title
The opioid system in depression
Authors
Keywords
-
Journal
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Volume 140, Issue -, Pages 104800
Publisher
Elsevier BV
Online
2022-07-30
DOI
10.1016/j.neubiorev.2022.104800
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Back to the Future: Esmethadone, the (Maybe) Nonopiate Opiate, and Depression
- (2022) Charles B. Nemeroff AMERICAN JOURNAL OF PSYCHIATRY
- The Roles of Endogenous Opioid System in the Antidepressant Actions of Ketamine
- (2021) Cheng Jiang et al. BIOLOGICAL PSYCHIATRY
- Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
- (2021) Jordi Bonaventura et al. MOLECULAR PSYCHIATRY
- The anterior cingulate cortex as a key locus of ketamine’s antidepressant action
- (2021) Laith Alexander et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- REL-1017 (Esmethadone) Increases Circulating BDNF Levels in Healthy Subjects of a Phase 1 Clinical Study
- (2021) Sara De Martin et al. Frontiers in Pharmacology
- Opioid receptor system contributes to the acute and sustained antidepressant-like effects, but not the hyperactivity motor effects of ketamine in mice
- (2021) Fan Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial
- (2021) Maurizio Fava et al. AMERICAN JOURNAL OF PSYCHIATRY
- Accuracy in recognising happy facial expressions is associated with antidepressant response to a NOP receptor antagonist but not placebo treatment
- (2021) Gerard R Dawson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders
- (2020) Moriah L. Jacobson et al. Annual Review of Pharmacology and Toxicology
- Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents
- (2020) Matthew E. Klein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protracted Effects of Ketamine Require Immediate Kappa Opioid Receptor Activation and Long‐Lasting Desensitization
- (2020) Moriah L. Jacobson et al. FASEB JOURNAL
- Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials
- (2020) Ziad Saad et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Kinetic modeling and test-retest reproducibility of 11C-EKAP and 11C-FEKAP, novel agonist radiotracers for PET imaging of the kappa opioid receptor in humans
- (2020) Mika Naganawa et al. JOURNAL OF NUCLEAR MEDICINE
- AP-1 controls the p11-dependent antidepressant response
- (2020) Revathy U. Chottekalapanda et al. MOLECULAR PSYCHIATRY
- A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia
- (2020) Andrew D. Krystal et al. NATURE MEDICINE
- Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety
- (2020) Lauri Nummenmaa et al. NEUROPSYCHOPHARMACOLOGY
- Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials
- (2020) Joanna Kryst et al. Pharmacological Reports
- The Role of BDNF on Neural Plasticity in Depression
- (2020) Tao Yang et al. Frontiers in Cellular Neuroscience
- Some Reasons Why Preclinical Studies of Psychiatric Disorders Fail to Translate: What Can Be Rescued from the Misunderstanding and Misuse of Animal ‘Models’?
- (2020) S. Clare Stanford ATLA-ALTERNATIVES TO LABORATORY ANIMALS
- Characteristics of tianeptine effects reported to a poison control center: a growing threat to public health
- (2020) William Rushton et al. CLINICAL TOXICOLOGY
- Endogenous Opiates and Behavior: 2018
- (2020) Richard J. Bodnar PEPTIDES
- The kappa opioid receptor antagonist aticaprant reverses behavioral effects from unpredictable chronic mild stress in male mice
- (2020) Moriah L. Jacobson et al. PSYCHOPHARMACOLOGY
- Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder
- (2019) Gihyun Yoon et al. JAMA Psychiatry
- Ketamine: A Paradigm Shift for Depression Research and Treatment
- (2019) John H. Krystal et al. NEURON
- The ERK Pathway: Molecular Mechanisms and Treatment of Depression
- (2019) John Q. Wang et al. MOLECULAR NEUROBIOLOGY
- Social status and demographic effects of the kappa opioid receptor: a PET imaging study with a novel agonist radiotracer in healthy volunteers
- (2019) David Matuskey et al. NEUROPSYCHOPHARMACOLOGY
- Towards robust functional neuroimaging genetics of cognition
- (2019) Julia Uddén et al. JOURNAL OF NEUROSCIENCE
- Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism
- (2019) Nolan R. Williams et al. MOLECULAR PSYCHIATRY
- Animal models of major depression: drawbacks and challenges
- (2019) Barbara Planchez et al. JOURNAL OF NEURAL TRANSMISSION
- Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data?
- (2019) Corey B. Puryear et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches
- (2018) Marta Peciña et al. MOLECULAR PSYCHIATRY
- The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects
- (2018) Chadi G. Abdallah et al. NEUROPSYCHOPHARMACOLOGY
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Kappa opioid receptor binding in major depression: A pilot study
- (2018) Jeffrey M. Miller et al. SYNAPSE
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
- (2018) Nolan R. Williams et al. AMERICAN JOURNAL OF PSYCHIATRY
- Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial
- (2018) Sanjeev Pathak et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The opioid system and the social brain: implications for depression and suicide
- (2018) Pierre-Eric Lutz et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Lack of Opioid System in the Antidepressant Actions of Ketamine
- (2018) Kai Zhang et al. BIOLOGICAL PSYCHIATRY
- Animal models of depression: pros and cons
- (2018) Jaanus Harro CELL AND TISSUE RESEARCH
- Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Prefrontal expectancy and reinforcement-driven antidepressant placebo effects
- (2018) M. Peciña et al. Translational Psychiatry
- Reversal of Stress-Induced Social Interaction Deficits by Buprenorphine
- (2017) Caroline A Browne et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- NK1 receptor antagonists for depression: Why a validated concept was abandoned
- (2017) Nadia M.J. Rupniak et al. JOURNAL OF AFFECTIVE DISORDERS
- Effects of tianeptine on symptoms of fibromyalgia via BDNF signaling in a fibromyalgia animal model
- (2017) Hwayoung Lee et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor
- (2017) Benjamin Adam Samuels et al. NEUROPSYCHOPHARMACOLOGY
- “Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats”
- (2017) Marta Valenza et al. PSYCHOPHARMACOLOGY
- Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial
- (2016) Maurizio Fava et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial
- (2016) Yoram Yovell et al. AMERICAN JOURNAL OF PSYCHIATRY
- Kappa Opioids, Salvinorin A and Major Depressive Disorder
- (2016) George T. Taylor et al. Current Neuropharmacology
- Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials
- (2016) William A. Carlezon et al. DEPRESSION AND ANXIETY
- HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition
- (2016) J Keller et al. MOLECULAR PSYCHIATRY
- Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures
- (2016) Ashley E. Lepack et al. NEUROPHARMACOLOGY
- Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors
- (2016) Edgardo Falcon et al. NEUROPSYCHOPHARMACOLOGY
- Social functioning in major depressive disorder
- (2016) Aleksandra Kupferberg et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Learned helplessness at fifty: Insights from neuroscience.
- (2016) Steven F. Maier et al. PSYCHOLOGICAL REVIEW
- A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression
- (2016) Erica M. Richards et al. PSYCHOPHARMACOLOGY
- Antidepressant-like effects of buprenorphine in rats are strain dependent
- (2015) Caroline A. Browne et al. BEHAVIOURAL BRAIN RESEARCH
- Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin/kappa-opioid receptor system
- (2015) Rachel J. Donahue et al. BEHAVIOURAL PHARMACOLOGY
- Test-Retest Reproducibility of Binding Parameters in Humans with 11C-LY2795050, an Antagonist PET Radiotracer for the Opioid Receptor
- (2015) M. Naganawa et al. JOURNAL OF NUCLEAR MEDICINE
- Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice
- (2015) Abdulrahman Almatroudi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Polygenic risk scores in imaging genetics: Usefulness and applications
- (2015) Danai Dima et al. JOURNAL OF PSYCHOPHARMACOLOGY
- It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder
- (2015) D T Hsu et al. MOLECULAR PSYCHIATRY
- A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies
- (2015) Anke Post et al. NEUROPSYCHOPHARMACOLOGY
- Opioid partial agonist buprenorphine dampens responses to psychosocial stress in humans
- (2015) Anya K. Bershad et al. PSYCHONEUROENDOCRINOLOGY
- Association Between Placebo-Activated Neural Systems and Antidepressant Responses
- (2015) Marta Peciña et al. JAMA Psychiatry
- A Word to the Wise About Ketamine
- (2014) Alan F. Schatzberg AMERICAN JOURNAL OF PSYCHIATRY
- Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors
- (2014) Daniela da Fonseca Pacheco et al. BRAIN RESEARCH
- Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Midlife and Older Adults
- (2014) Jordan F. Karp et al. JOURNAL OF CLINICAL PSYCHIATRY
- Anterior Cingulate Cortex: Unique Role in Cognition and Emotion
- (2014) Francis L. Stevens et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Molecular mechanisms of placebo responses in humans
- (2014) M Peciña et al. MOLECULAR PSYCHIATRY
- Evaluation of the agonist PET radioligand [11C]GR103545 to image kappa opioid receptor in humans: Kinetic model selection, test–retest reproducibility and receptor occupancy by the antagonist PF-04455242
- (2014) Mika Naganawa et al. NEUROIMAGE
- Effects of the Mu Opioid Receptor Polymorphism (OPRM1 A118G) on Pain Regulation, Placebo Effects and Associated Personality Trait Measures
- (2014) Marta Peciña et al. NEUROPSYCHOPHARMACOLOGY
- Evaluation of Opioid Modulation in Major Depressive Disorder
- (2014) Elliot Ehrich et al. NEUROPSYCHOPHARMACOLOGY
- Autistic-Like Syndrome in Mu Opioid Receptor Null Mice is Relieved by Facilitated mGluR4 Activity
- (2014) Jérôme AJ Becker et al. NEUROPSYCHOPHARMACOLOGY
- μ-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain
- (2014) W. Chen et al. NEUROSCIENCE
- Endogenous opioid system influences depressive reactions to socially painful targeted rejection life events
- (2014) George M. Slavich et al. PSYCHONEUROENDOCRINOLOGY
- Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice
- (2014) Edgardo Falcon et al. PSYCHOPHARMACOLOGY
- The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist
- (2014) M M Gassaway et al. Translational Psychiatry
- It’s MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system
- (2014) Elena H. Chartoff et al. Frontiers in Pharmacology
- The Kappa Opioid Receptor: From Addiction to Depression, and Back
- (2014) Laurence Lalanne et al. Frontiers in Psychiatry
- The Economic Burden of Treatment-Resistant Depression
- (2013) Natalia Olchanski et al. CLINICAL THERAPEUTICS
- Response of the μ-opioid system to social rejection and acceptance
- (2013) D T Hsu et al. MOLECULAR PSYCHIATRY
- Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans
- (2013) Talakad G. Lohith et al. NEUROIMAGE
- LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders
- (2013) Linda M. Rorick-Kehn et al. NEUROPHARMACOLOGY
- Kappa Opioid Receptors on Dopaminergic Neurons Are Necessary for Kappa-Mediated Place Aversion
- (2013) Vladimir I Chefer et al. NEUROPSYCHOPHARMACOLOGY
- Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs
- (2013) Elaine Cristina Gavioli et al. PHARMACOLOGY & THERAPEUTICS
- Tianeptine combination for partial or non-response to selective serotonin re-uptake inhibitor monotherapy
- (2013) Young Sup Woo et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Pharmacological activation of kappa opioid receptors: aversive effects in adolescent and adult male rats
- (2013) Rachel I. Anderson et al. PSYCHOPHARMACOLOGY
- Antidepressive effects of the κ-opioid receptor agonist salvinorin A in a rat model of anhedonia
- (2012) Mitchell T. Harden et al. BEHAVIOURAL PHARMACOLOGY
- Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR
- (2012) Jinsong Peng et al. DRUG AND ALCOHOL DEPENDENCE
- The role of mu opioid receptors in psychomotor stimulation and conditioned place preference induced by morphine-6-glucuronide
- (2012) Alexander T. Nguyen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The rewarding action of acute cocaine is reduced in β-endorphin deficient but not in μ opioid receptor knockout mice
- (2012) Alexander T. Nguyen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Active behaviours produced by antidepressants and opioids in the mouse tail suspension test
- (2012) Esther Berrocoso et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Ligand Directed Signaling Differences between Rodent and Human κ-Opioid Receptors
- (2012) Selena S. Schattauer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Effects of Reboxetine Treatment on Depression-like Behavior, Brain Neurotrophins, and ERK Expression in Rats Exposed to Chronic Mild Stress
- (2012) Maya First et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Brain and Whole-Body Imaging of Nociceptin/Orphanin FQ Peptide Receptor in Humans Using the PET Ligand 11C-NOP-1A
- (2012) T. G. Lohith et al. JOURNAL OF NUCLEAR MEDICINE
- The pain of social disconnection: examining the shared neural underpinnings of physical and social pain
- (2012) Naomi I. Eisenberger NATURE REVIEWS NEUROSCIENCE
- Neurotrophin regulation of neural circuit development and function
- (2012) Hyungju Park et al. NATURE REVIEWS NEUROSCIENCE
- Endogenous opioid systems: Current concepts and clinical correlations
- (2012) E. E. Benarroch NEUROLOGY
- Opioid receptors: distinct roles in mood disorders
- (2012) Pierre-Eric Lutz et al. TRENDS IN NEUROSCIENCES
- Treatment-resistant depression: therapeutic trends, challenges, and future directions
- (2012) Al-harbi Patient Preference and Adherence
- Modeling socially anhedonic syndromes: genetic and pharmacological manipulation of opioid neurotransmission in mice
- (2012) C Cinque et al. Translational Psychiatry
- Molecular Mechanisms of Opioid Receptor-dependent Signaling and Behavior
- (2011) Ream Al-Hasani et al. ANESTHESIOLOGY
- The novel δ opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions
- (2011) Akiyoshi Saitoh et al. BEHAVIOURAL BRAIN RESEARCH
- Repeated Exposure to the κ-Opioid Receptor Agonist Salvinorin A Modulates Extracellular Signal-Regulated Kinase and Reward Sensitivity
- (2011) David N. Potter et al. BIOLOGICAL PSYCHIATRY
- Synthesis and Evaluation of Radioligands for Imaging Brain Nociceptin/Orphanin FQ Peptide (NOP) Receptors with Positron Emission Tomography
- (2011) Victor W. Pike et al. JOURNAL OF MEDICINAL CHEMISTRY
- Activation of CREB in the Nucleus Accumbens Shell Produces Anhedonia and Resistance to Extinction of Fear in Rats
- (2011) J. W. Muschamp et al. JOURNAL OF NEUROSCIENCE
- Brain and Whole-Body Imaging in Rhesus Monkeys of 11C-NOP-1A, a Promising PET Radioligand for Nociceptin/Orphanin FQ Peptide Receptors
- (2011) Y. Kimura et al. JOURNAL OF NUCLEAR MEDICINE
- The Mu-Opioid Receptor and the NMDA Receptor Associate in PAG Neurons: Implications in Pain Control
- (2011) María Rodríguez-Muñoz et al. NEUROPSYCHOPHARMACOLOGY
- Social rejection shares somatosensory representations with physical pain
- (2011) E. Kross et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Influence of the OPRM1 gene polymorphism upon children's degree of withdrawal and brain activation in response to facial expressions
- (2011) Eleonora Bertoletti et al. Developmental Cognitive Neuroscience
- Deletion of the δ Opioid Receptor Gene Impairs Place Conditioning But Preserves Morphine Reinforcement
- (2010) Julie Le Merrer et al. BIOLOGICAL PSYCHIATRY
- Efficacy markers in depression
- (2010) Catherine J Harmer et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Peripheral BDNF Produces Antidepressant-Like Effects in Cellular and Behavioral Models
- (2010) Heath D Schmidt et al. NEUROPSYCHOPHARMACOLOGY
- Brain-derived neurotrophic factor: role in depression and suicide
- (2010) Yogesh Dwivedi Neuropsychiatric Disease and Treatment
- Dynorphin, stress, and depression
- (2009) Allison T. Knoll et al. BRAIN RESEARCH
- kappa-Opioid receptor signaling and brain reward function
- (2009) Adrie W. Bruijnzeel BRAIN RESEARCH REVIEWS
- Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient ofSalvia divinorum, in rodents
- (2009) Daniela Braida et al. BRITISH JOURNAL OF PHARMACOLOGY
- Opiates as Antidepressants
- (2009) Esther Berrocoso et al. CURRENT PHARMACEUTICAL DESIGN
- The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation
- (2009) B S McEwen et al. MOLECULAR PSYCHIATRY
- A new perspective on the role of the orbitofrontal cortex in adaptive behaviour
- (2009) Geoffrey Schoenbaum et al. NATURE REVIEWS NEUROSCIENCE
- Reward Processing by the Opioid System in the Brain
- (2009) Julie Le Merrer et al. PHYSIOLOGICAL REVIEWS
- Variation in the -opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection
- (2009) B. M. Way et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chronic treatment with the selective NOP receptor antagonist [Nphe1,Arg14,Lys15]N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats
- (2009) Giovanni Vitale et al. PSYCHOPHARMACOLOGY
- Opiate Treatment in Depression Refractory to Antidepressants and Electroconvulsive Therapy
- (2008) Peter W. Nyhuis et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Potent, Orally Bioavailable Delta Opioid Receptor Agonists for the Treatment of Pain: Discovery ofN,N-Diethyl-4-(5-hydroxyspiro[chromene-2,4′-piperidine]-4-yl)benzamide (ADL5859)
- (2008) Bertrand Le Bourdonnec et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress
- (2008) Xiaoli Qi et al. NEUROBIOLOGY OF DISEASE
- Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2
- (2008) Michael R. Bruchas et al. NEUROREPORT
- Control of hormonal stress reactivity by the endogenous opioid system
- (2008) Andras Bilkei-Gorzo et al. PSYCHONEUROENDOCRINOLOGY
- Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic–pituitary–adrenal axis in monkeys
- (2008) John E. Pascoe et al. PSYCHONEUROENDOCRINOLOGY
- Selective Loss of Brain-Derived Neurotrophic Factor in the Dentate Gyrus Attenuates Antidepressant Efficacy
- (2007) Megumi Adachi et al. BIOLOGICAL PSYCHIATRY
- Regionally Specific Regulation of ERK MAP Kinase in a Model of Antidepressant-Sensitive Chronic Depression
- (2007) Shannon L. Gourley et al. BIOLOGICAL PSYCHIATRY
- Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model
- (2007) Akiyoshi Saitoh et al. BRAIN RESEARCH
- Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist
- (2007) Raffaella Vergura et al. PEPTIDES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started